 Home > Medical News > Latest Medical News > China Resources Pharma's China Pharmaceutical Research Innovative Drug NIP003 Tablets Obtained Clinical Approval

China Resources Pharma's China Pharmaceutical Research Innovative Drug NIP003 Tablets Obtained Clinical Approval

 Last Update: 2022-05-27
 Source: Internet
 Author: User

Tags

cardiovascular drugs classification

jak inhibitor drugs

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On March 9, according to the official WeChat news of the China Pharmaceutical Research Institute, recently, NIP003 tablets, a new generation anticoagulant of the China Pharmaceutical Research Institute, a subsidiary of China Resources Pharma, obtained the "Notice of Drug Clinical Trial Approval" issued by the NMPA, and was approved for clinical use in the prevention of arteriovenous thrombosis.

NIP003 is a novel FXIa inhibitor with global intellectual property rights

In recent years, the incidence of cardiovascular and cerebrovascular diseases has been increasing year by year, and its high disability rate and high death rate pose a serious threat to people's health and bring a heavy burden to the society

Preclinical research data show that NIP003 has potent inhibitory activity against FXIa, and through structure-based molecular design, compared with the same target drug Milvexian, the off-target effect on plasma bradykininase and other targets is significantly improved.

Reference source: Financial Associated Press, China Resources Pharma official website

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.